Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ipsen sa-nv - clostridium botulinum toxin type a - powder for solution for injection - 500 u - clostridium botulinum toxin, type a, hemagglutinine complex 500 u - botulinum toxin

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

abbvie sa-nv - clostridium botulinum toxin type a - powder for solution for injection - 4 allergan u/0,1 ml - clostridium botulinum toxin, type a 50 u - botulinum toxin

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

abbvie sa-nv - clostridium botulinum toxin type a - powder for solution for injection - 4 allergan u/0,1 ml - clostridium botulinum toxin, type a 100 u - botulinum toxin

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

merz pharmaceuticals gmbh - clostridium botulinum toxin type a - powder for solution for injection - 50 u - clostridium botulinum toxin, type a 50 u - botulinum toxin

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

merz pharmaceuticals gmbh - clostridium botulinum toxin type a - powder for solution for injection - 100 u - clostridium botulinum toxin, type a 100 u - botulinum toxin

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

merz pharmaceuticals gmbh - clostridium botulinum toxin type a - powder for solution for injection - 200 u - clostridium botulinum toxin, type a 200 u - botulinum toxin

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ipsen pharma - clostridium botulinum toxin type a - solution for injection - clostridium botulinum toxin, type a - botulinum toxin

Israel - English - Ministry of Health

alphamedix ltd, israel - botulinum toxin type a - powder for solution for injection - botulinum toxin type a 0.8 ng 100 ld50 units / vial - botulinum toxin - xeomin is indicated for the symptomatic treatment of blepharospasm, cervical dystonia of a predominantly rotational form (spasmodic torticollis) and of post-stroke spasticity of the upper limb presenting with flexed wrist and clenched fist in adult. xeomin is indicated for the temporary improvement in the appearance of moderate to severe vertical lines between eyebrows seen at frown (glabellar frown lines) in adults below 65 years when the severity of these lines has an important psychological impact for the patient

Israel - English - Ministry of Health

alphamedix ltd, israel - botulinum toxin type a - powder for solution for injection - botulinum toxin type a 0.2 - 0.4 ng 50 ld50 units / vial - botulinum toxin - xeomin is indicated for the symptomatic treatment of blepharospasm, cervical dystonia of a predominantly rotational form (spasmodic torticollis) and of post-stroke spasticity of the upper limb presenting with flexed wrist and clenched fist in adult. xeomin is indicated for the temporary improvement in the appearance of moderate to severe vertical lines between eyebrows seen at frown (glabellar frown lines) in adults below 65 years when the severity of these lines has an important psychological impact for the patient

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - botulinum toxin type a 100 units equivalent to incobotulinumtoxina (usan), purified botulinum toxin type a - powder for injection - 100 units - active: botulinum toxin type a 100 units equivalent to incobotulinumtoxina (usan), purified botulinum toxin type a excipient: albumin sucrose - xeomin is indicated in adults for the treatment of: · cervical dystonia · blepharospasm · spasticity of the upper limb · upper facial lines -glabellar frown lines -lateral periorbital lines (crow's feet) - horizontal forehead lines